BRAF polymorphisms and the risk of ovarian cancer of low malignant potential

Gynecologic Oncology

Volumn 97, Issue 3, 2005, Pages 807-812

  Kelemen, Livia ^a   James, Michael ^a   Spurdle, Amanda ^a   Campbell, Ian ^b   Chang Claude, Jenny ^c   Peel, David ^d   Anton Culver, Hoda ^d   Berchuck, Andrew ^e   Schildkraut, Joellen ^e   Whittemore, Alice ^f   McGurie, Valerie ^f   DiCioccio, Richard A ^g   Duffy, David ^b   Chenevix Trench, Georgia ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

BRAF; LMP; Low malignant potential; Ovarian cancer; Polymorphism; Susceptibility

Indexed keywords

B RAF KINASE;

ARTICLE; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HISTOLOGY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OVARY CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 20444439054     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.03.007     Document Type: Article

References (29)

1. P. Russell Surface epithelial-stromal tumors of the ovary R.J. Kurman Blaustein's Pathology of the Female Genital Tract 1994 Springer-Verlag New York 705 782
2. M. Shih, and R.J. Kurman Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis Am. J. Pathol. 164 5 2004 1511 1518
3. C.L. Trimble, and E.L. Trimble Ovarian tumors of low malignant potential Oncology (Huntingt) 17 11 2003 1563 1567 [discussion 7-70, 75]
4. M.A. Crispens Borderline ovarian tumours: a review of the recent literature Curr. Opin. Obstet. Gynecol. 15 1 2003 39 43
5. P.M. Pollock, U.L. Harper, K.S. Hansen, L.M. Yudt, M. Stark, and C.M. Robbins High frequency of BRAF mutations in nevi Nat. Genet. 33 1 2003 19 20
6. H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, and S. Clegg Mutations of the BRAF gene in human cancer Nature 417 6892 2002 949 954
7. J. Dong, R.G. Phelps, R. Qiao, S. Yao, O. Benard, and Z. Ronai BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma Cancer Res. 63 14 2003 3883 3885
8. E.T. Kimura, M.N. Nikiforova, Z. Zhu, J.A. Knauf, Y.E. Nikiforov, and J.A. Fagin High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma Cancer Res. 63 7 2003 1454 1457
9. S.T. Yuen, H. Davies, T.L. Chan, J.W. Ho, G.R. Bignell, and C. Cox Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia Cancer Res. 62 22 2002 6451 6455
10. K. Naoki, T.H. Chen, W.G. Richards, D.J. Sugarbaker, and M. Meyerson Missense mutations of the BRAF gene in human lung adenocarcinoma Cancer Res. 62 23 2002 7001 7303
11. M.S. Brose, P. Volpe, M. Feldman, M. Kumar, I. Rishi, and R. Gerrero BRAF and RAS mutations in human lung cancer and melanoma Cancer Res. 62 23 2002 6997 7000
12. N.L. Sieben, P. Macropoulos, G.M. Roemen, S.M. Kolkman-Uljee, G. Jan Fleuren, and R. Houmadi In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours J. Pathol. 202 3 2004 336 340
13. G. Singer, R. Oldt III, Y. Cohen, B.G. Wang, D. Sidransky, and R.J. Kurman Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma J. Natl. Cancer Inst. 95 6 2003 484 486
14. R.M. Wenham, J.M. Lancaster, and A. Berchuck Molecular aspects of ovarian cancer Best Pract. Res. Clin. Obstet. Gynaecol. 16 4 2002 483 497
15. J. Boyd, and S.C. Rubin Hereditary ovarian cancer: molecular genetics and clinical implications Gynecol. Oncol. 64 2 1997 196 206
16. P. Meyer, C. Sergi, and C. Garbe Polymorphisms of the BRAF gene predispose males to malignant melanoma J. Carcinog. 2 1 2003 7
17. James MR, Roth RB, Shi MM, Kammerer S, Nelson MR, Stark MS, et al. BRAF polymorphisms and risk of melanocytic neoplasia (personal communication).
18. V. McGuire, A. Felberg, M. Mills, K.L. Ostrow, R. DiCioccio, and E.M. John Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations Am. J. Epidemiol. 160 7 2004 613 618
19. A. Lum, and L. Le Marchand A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies Cancer Epidemiol., Biomarkers Prev. 7 8 1998 719 724
20. D. Purdie, A. Green, C. Bain, V. Siskind, B. Ward, and N. Hacker Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group Int. J. Cancer 62 6 1995 678 684
21. G. Chenevix-Trench, J. Kerr, T. Hurst, Y.C. Shih, D. Purdie, and L. Bergman Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations Genes Chromosomes Cancer 18 2 1997 75 83
22. S. Levi, A. Urbano Ispizua, R. Gill, D.M. Thomas, J. Gilbertson, and C. Foster Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique Cancer Res. 51 13 1991 3497 3502
23. J. Royar, H. Becher, and J. Chang-Claude Low-dose oral contraceptives: protective effect on ovarian cancer risk Int. J. Cancer 95 6 2001 370 374
24. R. Mullenbach, P.J. Lagoda, and C. Welter An efficient salt-chloroform extraction of DNA from blood and tissues Trends Genet 5 12 1989 391
25. A. Bansal, D. van den Boom, S. Kammerer, C. Honisch, G. Adam, and C.R. Cantor Association testing by DNA pooling: an effective initial screen Proc. Natl. Acad. Sci. U. S. A. 99 26 2002 16871 16874
26. R Development Core T. R: a language and environment for statistical computing. R Foundation for Statistical Computing 2004, Vienna Austria. ISBN 3-90005100-3: http://www.R-project.org.
27. D.J. Schaid, C.M. Rowland, D.E. Tines, R.M. Jacobson, and G.A. Poland Score tests for association between traits and haplotypes when linkage phase is ambiguous Am. J. Hum. Genet. 70 2 2002 425 434
28. S.L. Lake, H. Lyon, K. Tantisira, E.K. Silverman, S.T. Weiss, and N.M. Laird Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous Hum. Hered. 55 1 2003 56 65
29. The Breast Cancer Linkage Consortium Cancer risks in BRCA2 mutation carriers J. Natl. Cancer Inst. 91 15 1999 1310 1316